Nonnarcotic analgesics and hypertension

被引:23
作者
Gaziano, J. Michael
机构
[1] Harvard Univ, Sch Med, Div Aging, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA
[3] Harvard Univ, Sch Med, Div Cardiovasc Med, Boston, MA USA
[4] MAVERIC, Vet Affairs Boston Healthcare Syst, Boston, MA USA
关键词
D O I
10.1016/j.amjcard.2006.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 2004, individuals in the United States spent >$2.5 billion on over-the-counter (OTC) nonsteroidal anti-inflammatory drugs (NSAIDs) and filled > 100 million NSAID prescriptions. The most commonly used OTC analgesics include aspirin, acetaminophen, and nonaspirin NSAIDs. Normarcotic analgesics are generally considered safe when used as directed but do have the potential to increase blood pressure in patients with hypertension treated with antihypertensives. This is important because hypertension alone has been correlated with an increased risk of cardiovascular disease or stroke. Small increases in blood pressure in patients with hypertension also have been shown to increase cardiovascular morbidity and mortality. Therefore, when nonnarcotic analgesics are taken by patients with hypertension, there may be important implications. This review explores the potential connection among analgesic agents, blood pressure, and hypertension, and discusses possible mechanisms by which analgesics might cause increases in blood pressure. This is followed by a summary of data on the relation between analgesics and blood pressure from both observational and randomized trials. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:10E / 16E
页数:7
相关论文
共 46 条
  • [1] Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure
    Aw, TJ
    Haas, SJ
    Liew, D
    Krum, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (05) : 490 - 496
  • [2] Nonsteroidal anti-inflammatory drugs and heart failure
    Bleumink, GS
    Feenstra, J
    Sturkenboom, MCJM
    Stricker, BHC
    [J]. DRUGS, 2003, 63 (06) : 525 - 534
  • [3] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    Day, R
    Ferraz, MB
    Hawkey, CJ
    Hochberg, MC
    Kvien, TK
    Schnitzer, TJ
    Weaver, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
  • [4] Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735
  • [5] Centers for Disease Control and Prevention (CDC), 2002, MMWR MORB MORTAL WKL, V51, P948
  • [6] NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND BLOOD-PRESSURE IN AN ELDERLY POPULATION
    CHRISCHILLES, EA
    WALLACE, RB
    [J]. JOURNALS OF GERONTOLOGY, 1993, 48 (03): : M91 - M96
  • [7] Role of prostaglandins in hypertension
    Colina-Chourio, JA
    Godoy-Godoy, N
    Avila-Hernández, RM
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) : S16 - S19
  • [8] Lifetime nonnarcotic analgesic use and decline in renal function in women
    Curhan, GC
    Knight, EL
    Rosner, B
    Hankinson, SE
    Stampfer, MJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (14) : 1519 - 1524
  • [9] Cushman William C, 2003, J Clin Hypertens (Greenwich), V5, P14, DOI 10.1111/j.1524-6175.2003.02464.x
  • [10] Nonnarcotic analgesic use and the risk of hypertension in US women
    Dedier, J
    Stampfer, MJ
    Hankinson, SE
    Willett, WC
    Speizer, FE
    Curhan, GC
    [J]. HYPERTENSION, 2002, 40 (05) : 604 - 608